Oct 07, 2015 7:00 am EDT Heat Biologics to Participate in the Annual Prostate Cancer Foundation Scientific Retreat
Sep 16, 2015 9:01 am EDT Heat Biologics to Present New Data on Its ComPACT Platform at the CRI-CIMT-EATI-AACR Inaugural International Cancer Immunotherapy Conference
Sep 02, 2015 8:00 am EDT Heat Biologics, Inc. to Present at the 17th Annual Global Investment Conference
Sep 01, 2015 7:00 am EDT Heat Biologics Announces Clinical Trial Combining HS-110 and PD-1 Checkpoint Inhibitor in NSCLC
Aug 13, 2015 8:00 am EDT Heat Biologics Announces Financial Results for the Second Quarter Ended June 30, 2015
Jul 27, 2015 8:00 am EDT Heat Biologics, Inc. Announces Promotions of Taylor Schreiber, M.D., Ph.D., to Chief Scientific Officer, and Melissa Price, Ph.D., to Vice President of Product Development
Jul 01, 2015 8:00 am EDT Heat Biologics, Inc. to Present at the Cantor Fitzgerald Healthcare Conference
Jun 15, 2015 7:00 am EDT Heat Biologics Announces Development of ComPACT, a Next Generation Combination Immunotherapy Platform
May 29, 2015 8:00 am EDT Heat Biologics, Inc. to Present Interim Immune Response Data From Ongoing Phase II Trial With HS-110 in Advanced NSCLC at ASCO